Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06282133
Status:
RECRUITING
Last Update Posted:
2024-02-28
First Post:
2024-01-31
Brief Title:
Behavioural Experiments for Generalized Anxiety in Adolescents - Pilot Study
Sponsor:
Universite du Quebec en Outaouais
Organization:
Universite du Quebec en Outaouais
Study Overview
Official Title:
Behavioural Experiments for Intolerance of Uncertainty A Novel Treatment for Generalized Anxiety Disorder in Adolescents - A Pilot Study
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EC-II-Ado-P
Brief Summary:
Generalized Anxiety Disorder GAD is a chronic condition characterized by excessive and uncontrollable worry and anxiety In adolescents this condition can seriously impact their development academic performance and social relationships In Canada 3 to 4 of the population between 09 and 27 among adolescents suffers from GAD at any given time in their lives These young individuals experience a reduced quality of life and are at risk for numerous medical conditions as well as additional psychological issues Research suggests that both pharmacological and psychological approaches are effective in treating GAD in the short term However psychological treatments appear to offer the greatest long-term benefits There are a number of effective psychological treatments for GAD most of which fall under cognitive-behavioural therapy CBT adapted for this age group
In the 1990s a group of Canadian researchers developed a CBT protocol for GAD that included four components Data from six clinical trials in adults suggest that one of the four components is particularly important for treatment success exposing oneself to uncertainty rather than avoiding it in daily life In other words learning to tolerate and manage uncertainty seems to be the key to reducing worry and anxiety
Given this discovery researchers developed a new treatment that exclusively targets intolerance to uncertainty and then adapted it for adolescents Behavioural Experiments for Intolerance to Uncertainty in Adolescents EC-IIA The aim of the current pilot study is to test the effectiveness of EC-IIA in adolescent individuals A total of 8 participants with a primary diagnosis of GAD will receive EC-IIA and will be evaluated at 4 different times ranging from pre-treatment to a 6-month follow-up Conditions will be compared in terms of treatment efficacy and mechanisms Researchers will also examine predictors of change during the 6 months following treatment The proposed study will produce data on the effectiveness and mechanisms of a treatment for GAD that is less costly less complex and easier to disseminate than currently available treatments
In the 1990s a group of Canadian researchers developed a CBT protocol for GAD that included four components Data from six clinical trials in adults suggest that one of the four components is particularly important for treatment success exposing oneself to uncertainty rather than avoiding it in daily life In other words learning to tolerate and manage uncertainty seems to be the key to reducing worry and anxiety
Given this discovery researchers developed a new treatment that exclusively targets intolerance to uncertainty and then adapted it for adolescents Behavioural Experiments for Intolerance to Uncertainty in Adolescents EC-IIA The aim of the current pilot study is to test the effectiveness of EC-IIA in adolescent individuals A total of 8 participants with a primary diagnosis of GAD will receive EC-IIA and will be evaluated at 4 different times ranging from pre-treatment to a 6-month follow-up Conditions will be compared in terms of treatment efficacy and mechanisms Researchers will also examine predictors of change during the 6 months following treatment The proposed study will produce data on the effectiveness and mechanisms of a treatment for GAD that is less costly less complex and easier to disseminate than currently available treatments
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None